135 related articles for article (PubMed ID: 21303827)
1. Immunoadsorption (IAS) for systemic lupus erythematosus.
Stummvoll GH
Lupus; 2011 Feb; 20(2):115-9. PubMed ID: 21303827
[TBL] [Abstract][Full Text] [Related]
2. Immunoadsorption for systemic lupus erythematosus.
Stummvoll GH; Julius U; Derfler K; Aringer M
Atheroscler Suppl; 2009 Dec; 10(5):110-3. PubMed ID: 20129387
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption in Autoimmune Diseases Affecting the Kidney.
Stummvoll G; Aringer M; Handisurya A; Derfler K
Semin Nephrol; 2017 Sep; 37(5):478-487. PubMed ID: 28863794
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
5. Lupus nephritis: prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity.
Stummvoll GH; Schmaldienst S; Smolen JS; Derfler K; Biesenbach P
Nephrol Dial Transplant; 2012 Feb; 27(2):618-26. PubMed ID: 21617196
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review.
Kronbichler A; Brezina B; Quintana LF; Jayne DR
Autoimmun Rev; 2016 Jan; 15(1):38-49. PubMed ID: 26318215
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption (IAS) as a rescue therapy in SLE: considerations on safety and efficacy.
Stummvoll GH; Aringer M; Jansen M; Smolen JS; Derfler K; Graninger WB
Wien Klin Wochenschr; 2004 Nov; 116(21-22):716-24. PubMed ID: 15628641
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption onto protein A induces remission in severe systemic lupus erythematosus.
Braun N; Erley C; Klein R; Kötter I; Saal J; Risler T
Nephrol Dial Transplant; 2000 Sep; 15(9):1367-72. PubMed ID: 10978392
[TBL] [Abstract][Full Text] [Related]
9. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
[TBL] [Abstract][Full Text] [Related]
10. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
11. Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus.
Huang J; Song G; Yin Z; He W; Zhang L; Kong W; Ye Z
Clin Rheumatol; 2016 Sep; 35(9):2211-8. PubMed ID: 27488202
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
Gaubitz M; Seidel M; Kummer S; Schotte H; Perniok A; Domschke W; Schneider M
J Autoimmun; 1998 Oct; 11(5):495-501. PubMed ID: 9802935
[TBL] [Abstract][Full Text] [Related]
13. Immunoadsorption in systemic lupus erythematosus: different techniques and their current role in medical therapy.
Gaubitz M; Schneider KM
Ther Apher Dial; 2003 Apr; 7(2):183-8. PubMed ID: 12918941
[TBL] [Abstract][Full Text] [Related]
14. Effect of immunoadsorption on patient with rheumatoid arthritis or SLE.
Yamazaki Z; Fujimori Y; Iizuka I; Kanai F; Idezuki Y; Takahama T; Asano K; Takahashi K; Ogita T; Miyamoto Y
Trans Am Soc Artif Intern Organs; 1984; 30():211-6. PubMed ID: 6398545
[No Abstract] [Full Text] [Related]
15. Immunoadsorption for connective tissue disease.
Hohenstein B; Bornstein SR; Aringer M
Atheroscler Suppl; 2013 Jan; 14(1):185-9. PubMed ID: 23357163
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Terrier B; Amoura Z; Ravaud P; Hachulla E; Jouenne R; Combe B; Bonnet C; Cacoub P; Cantagrel A; de Bandt M; Fain O; Fautrel B; Gaudin P; Godeau B; Harlé JR; Hot A; Kahn JE; Lambotte O; Larroche C; Léone J; Meyer O; Pallot-Prades B; Pertuiset E; Quartier P; Schaerverbeke T; Sibilia J; Somogyi A; Soubrier M; Vignon E; Bader-Meunier B; Mariette X; Gottenberg JE;
Arthritis Rheum; 2010 Aug; 62(8):2458-66. PubMed ID: 20506527
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of end-points in clinical trials.
Bertsias G; Gordon C; Boumpas DT
Lupus; 2008 May; 17(5):437-42. PubMed ID: 18490423
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis on the efficacy and safety of immunoadsorption for systemic lupus erythematosus among Chinese population.
Yang M; Liao C; Zhu Q; Lin X; Yang B; Zhao D; Li J; Deng D; Zhang W
Clin Rheumatol; 2020 Dec; 39(12):3581-3592. PubMed ID: 32468321
[TBL] [Abstract][Full Text] [Related]
20. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus.
Sun L; Wang D; Liang J; Zhang H; Feng X; Wang H; Hua B; Liu B; Ye S; Hu X; Xu W; Zeng X; Hou Y; Gilkeson GS; Silver RM; Lu L; Shi S
Arthritis Rheum; 2010 Aug; 62(8):2467-75. PubMed ID: 20506343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
